An approach to high-level production of a mecasermin (Somatomedin C) fused protein in Escherichia coli HB101

Journal of Fermentation and Bioengineering

Volumn 82, Issue 2, 1996, Pages 128-133

  Noguchi, Yuji ^a   Satoh, Susumu ^a   Yamaguchi, Michitaka ^a   Watanabe, Katsuyuki ^a   Hayashi, Masako ^a   Yamada, Hisashi ^a   Saito, Yoshimasa ^a   Kobayashi, Masakazu ^a   Shimomura, Kyoichi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Escherichia coli HB101; fed batch cultivation; mecasermin; recombinant DNA; somatomedin C

Indexed keywords

HYBRID PROTEIN; SOMATOMEDIN C;

ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; ESCHERICHIA COLI; GROWTH INHIBITION; NONHUMAN; PROTEIN SYNTHESIS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0029815499     PISSN: 0922338X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0922-338X(96)85034-3     Document Type: Article

References (27)

1. Rinderknecht, E. and Humbel, R. E.: The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J. Biol. Chem., 253, 2769-2776 (1978).
2. Humbel, R. E.: Insulin-like growth factors I and II. Eur. J. Biochem., 190, 445-462 (1990).
3. Daughday, W. H., Hall, K., Raben, M. S., Salmon, W. D., Jr., van den Brande, J. L., and van Wyk, J. J.: Somatomedin: Proposed designation for sulphation factor. Nature (London), 235, 107 (1972).
4. Laron, Z., Anin, S., Klipper-Aurabach, Y., and Klinger, B.: Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet, 339, 1285-1261 (1992).
5. Matsao, N., Yasukura, M., Eito, Y., Sasaki, N., Okada, S., Tajiri, H., Nose, O., and Nishi, M.: Effects of FK 780 (recombinant hIGF-I) on growth hormone insensitivity syndromes. Jpn. Pharmacol. Ther., 20, 2027-2035 (1992). (in Japanese)
6. Kuzuya, H., Matsuura, N., Sakamoto, M., Makino, H., Sakamoto, Y., Kadowaki, T., Suzuki, Y., Kobayashi, M., Akazawa, Y., Nomura, M., Yoshimasa, Y., Kasuga, M., Goji, K., Nagataki, S., Oyasu, H., and Imura, H.: Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes, 42, 696-705 (1993).
7. Quin, J. D., Smith, K., Beastall, G. H., Miell, J. P., and MacCuish, A. C.: The effect of recombinant insulin-like growth factor I on ketone body, lipid and apolipoprotein concentrations and its use to treat ketoacidosis in severe insulin resistance. Diabetic Medicine, 11, 590-592 (1994).
8. Takano, K.: Clinical use of IGF-I. Clinical Endocrinology, 42, 959-969 (1994). (in Japanese)
9. Peters, M. A., Lau, E. P., Snitman, D. L., van Wyk, J. J., Underwood, L. E., Russell, W. E., and Svoboda, M. E.: Expression of a biologically active analogue of somatomedin-C/ insulin-like growth factor I. Gene, 35, 83-89 (1985).
10. Moks, T., Abrahamsen, L., Holmgren, E., Bilich, M., Olsson, A., Uhlen, M., Pohl, G., Sterky, C., Hultberg, H., Josephson, S., Holmgren, A., Jornvall, H., and Nilsson, B.: Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification. Biochemistry, 26, 5239-5244 (1987).
11. Moks, T., Abrahamsen, L., Osterlof, B., Josephson, S., Ostling, M., Enfors, S.-O., Persson, I., Nilsson, B., and Uhlen, M.: Large-scale affinity purification of human insulin-like growth factor I from culture medium of Escherichia coli. Biotechnol., 5, 379-382 (1987).
12. Forsberg, G., Palm, G., Ekebacke, A., Josephson, S., and Hartmanis, M.: Separation and characterization of modified variants of recombinant human insulin-like growth factor-I derived from a fusion protein secreted from Escherichia coli. Biochem. J., 271, 357-363 (1990).
13. Wong, E. Y., Seetharam, R., Kotts, C. E., Heeren, R. A., Klein, B. K., Braford, S. R., Mathis, K. J., Bishop, B. F., Siegel, N. R., Smith, C. E., and Tacon, W. C.: Expression of secreted insulin-like growth factor-I in Escherichia coli. Gene, 68, 193-203 (1988).
14. Saito, Y., Yamada, H., Niwa, M., and Ueda, I.: Production and isolation of recombinant somatomedin C. J. Biochem., 101, 123-134 (1987).
15. Shimizu, N., Fukuzono, S., Harada, Y., Fujimori, K., Gotoh, K., and Yamazaki, Y.: Mass production of human epidermal growth factor using fed-batch cultures of recombinant Escherichia coli. Biotechnol. Bioeng., 38, 37-42 (1991).
16. Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najarian, R., Simonsen, C. C., Derynck, R., Sherwood, P. J., Wallace, D. M., Berger, S. L., Levinson, A. D., and Goeddel, D. V.: Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (London), 295, 503-508 (1982).
17. Salto, Y., Ishii, Y., Koyama, S., Tsuji, K., Yamada, H., Terai, T., Kobayashi, M., Ono, T., Niwa, M., Ueda, I., and Kikuchi, H.: Bacterial synthesis of recombinant α-human atrial natriuretic polypeptide. J. Biochem., 102, 111-122 (1987).
18. Sambrook, J., Fritsch, E. F., and Maniatis, T.: Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1989).
19. Maxam, A. M. and Gilbert, W.: Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol., 65, 499-560 (1980).
20. Twigg, A. J. and Sherratt, D.: Trans-complementable copy-number mutants of plasmid ColE1. Nature (London), 283, 216-218 (1980).
21. Goeddel, D. V., Yelverton, E., Ullrich, A., Heyneker, H. L., Miozzari, G., Holmes, W., Seeburg, P. H., Dull, T., May, L., Stebbing, N., Crea, R., Maeda, S., McCandliss, R., Sloma, A., Tabor, J. M., Gross, M., Familletti, P. C., and Pestka, S.: Human leucocyte interferon produced by E. coli is biologically active. Nature (London), 287, 411-416 (1980).
22. Windass, J. D., Newton, C. R., de Maeyer-Guignard, J., Moore, V. E., Matrkham, A. F., and Edge, M. D.: The construction of a synthetic Escherichia coli trp promoter and its use in the expression of a synthetic interferon gene. Nucl. Acids Res., 10, 6639-6657 (1982).
23. Betenbaugh, M. J., Beaty, C., and Dhurjati, P.: Effects of plasmid amplification and recombinant gene expression on the growth kinetics of recombinant E. coli. Biotechnol. Bioeng., 33, 1425-1436 (1989).
24. Mon, H., Yano, T., Kobayashi, T., and Shimizu, S.: High density cultivation of biomass in fed-batch system with DO-stat. J. Chem. Eng. Japan, 12, 313-319 (1979).
25. Mizutani, S., Mori, H., Shimizu, S., Sakaguchi, K., and Kobayashi, T.: Effect of amino acid supplement on cell yield and gene product in Escherichia coli harboring plasmid. Biotechnol. Bioeng., 28, 204-209 (1986).
26. de Felice, M. and Levinthal, M.: The acetohydroxy acid synthase III isoenzyme of Escherichia coli K-12: regulation of synthesis by leucine. Biochem. Biophys. Res. Commun., 79, 82-87 (1977).
27. Tavori, H., Kimmel, Y., and Barak, Z.: Toxicity of leucine-containing peptide in Escherichia coli caused by circumvention of leucine transport regulation. J. Bacteriol., 146, 676-683 (1981).